CJC-1295 (no DAC) (Modified GRF) is a truncated peptide analogue of growth hormone releasing hormone (GHRH). First developed in the 1980s, research studies with modGRF have shown it to improve muscle repair and growth, accelerate wound healing, strengthen bones, increase fat burning, and improve metabolism. It may also have beneficial effects on blood sugar regulation and the immune system.
Key Research Applications:
- Growth hormone receptor pathway studies
- Cellular longevity research
- Peptide stability investigations
- Biomarker analysis in controlled environments
Product Specifications:
- Purity: >99% (verified by HPLC/MS)
- Molecular Weight: ~3,647 Da
- Storage: Lyophilized powder, stable at room temperature
- Reconstitution: Bacteriostatic water recommended
For research use only. Not intended for human consumption.
CJC-1295 no DAC 2mg (Mod GRF 1-29)
₹8,000.00Price
- Typical dosages can range, but commonly it’s 2mg per vial, which can be reconstituted with sterile water.
- The peptide is typically administered via subcutaneous injection.
- The dosing regimen often involves one injection per week, as it has a prolonged half-life (due to the DAC component).
- As with any peptide, there could be risks, such as injection site reactions, water retention, or possible changes in insulin sensitivity.
- It’s important to monitor health regularly and consult with a healthcare provider, especially if using for long-term purposes.